Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Victory Pharma Inc
WARNING LETTER
•Victory Pharma Inc

Victory Pharma Inc – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to Victory Pharma, Inc. on November 13, 2009, following information obtained during an inspection of a manufacturer, (b)(4), with whom Victory Pharma contracted. The letter identifies that Victory Pharma marketed unapproved new drugs, specifically (b)(4) and (b)(4), which are intended for disease treatment and lack FDA-approved applications under sections 505(b) or (j) of the Federal Food, Drug, and Cosmetic Act (the "Act").

These products are deemed "new drugs" under section 201(p) of the Act because they are not generally recognized as safe and effective. Their introduction into interstate commerce without approved applications violates sections 301(d) and 505(a) of the Act [21 U.S.C. §§ 331(d), 355(a)].

Furthermore, the prescription drug products are misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)] because they lack adequate directions for use by a layman, as required by 21 C.F.R. § 201.5, and are not exempt under 21 C.F.R. § 201.115 due to the absence of approved applications. The products

Company
Victory Pharma Inc
Product type
Drugs
Office
Los Angeles District Office
Person
  • District Director
View Company Profile

ID · 1d35069a-735b-4f06-8084-e0a1ec977111

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 351(a)(2)(B)21 U.S.C. 331(a)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 355(b)21 U.S.C. 355(j)21 U.S.C. 352(f)(1)21 CFR 201.5

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Victory Pharma Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.